You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • GP41 DIVERSITY IN ANTIRETROVIRAL THERAPY NAïVE AND EXPERIENCED HIV-1 SUBTYPE C-INFECTED PATIENTS IN BOTSWANA: IMPLICATIONS FOR ENFUVIRTIDE (T-20) USE

Citation Tools

Article menu

Download PDFPDF

XML
ABSTRACTS OF THE EIGHTH EDCTP FORUM, 6–9 NOVEMBER 2016
ABSTRACTS OF POSTER PRESENTATIONS
PA-072
GP41 DIVERSITY IN ANTIRETROVIRAL THERAPY NAïVE AND EXPERIENCED HIV-1 SUBTYPE C-INFECTED PATIENTS IN BOTSWANA: IMPLICATIONS FOR ENFUVIRTIDE (T-20) USE

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Maruapula D, Seraise B, Einkauf K, et al
GP41 DIVERSITY IN ANTIRETROVIRAL THERAPY NAïVE AND EXPERIENCED HIV-1 SUBTYPE C-INFECTED PATIENTS IN BOTSWANA: IMPLICATIONS FOR ENFUVIRTIDE (T-20) USE
BMJ Global Health 2017;2:A39-A40.